Evolutionary modelling of HCV subtypes provides rationale for their different disease outcomes
Preprint
Abstract
Hepatitis C virus (HCV) is a leading cause of liver-associated disease and liver cancer. Of the major HCV subtypes, patients infected with subtype 1b have been associated with having a higher risk of developing chronic infection, cirrhosis and hepatocellular carcinoma. However, underlying reasons for this increased disease severity remain unknown. Here, we provide an evolutionary rationale, based on a comparative study of fitness landscape and in-host evolutionary models of the envelope glycoprotein 2 (E2) of HCV subtypes 1a and 1b. Our analysis demonstrates that a higher chronicity rate of subtype 1b may be attributed to lower fitness constraints, enabling 1b viruses to more easily escape antibody responses. More generally, our results suggest that differences in evolutionary constraints between HCV subtypes may be an important factor in mediating distinct disease outcomes. Our analysis also identifies antibodies that appear to be escape-resistant against both subtypes 1a and 1b, providing directions for the design of HCV vaccines having cross-subtype protection.Keywords
This publication has 75 references indexed in Scilit:
- Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan AfricaAIDS, 2013
- Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1Proceedings of the National Academy of Sciences, 2012
- Direct-coupling analysis of residue coevolution captures native contacts across many protein familiesProceedings of the National Academy of Sciences of the United States of America, 2011
- Chronic Hepatitis C InfectionNew England Journal of Medicine, 2011
- Coordinate linkage of HIV evolution reveals regions of immunological vulnerabilityProceedings of the National Academy of Sciences, 2011
- Viral Mutation RatesJournal of Virology, 2010
- Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus InfectivityJournal of Virology, 2009
- Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In VivoJournal of Virology, 2009
- Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysisJournal of Hepatology, 2009
- A Point Mutation Leading to Hepatitis C Virus Escape from Neutralization by a Monoclonal Antibody to a Conserved Conformational EpitopeJournal of Virology, 2008